190 results
8-K
EX-10.1
SRNEQ
Sorrento Therapeutics, Inc.
3 Nov 23
Entry into a Material Definitive Agreement
5:31pm
8-K
EX-10.1
SRNEQ
Sorrento Therapeutics, Inc.
26 Sep 23
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-10.1
SRNEQ
Sorrento Therapeutics, Inc.
10 Aug 23
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-10.1
SRNEQ
Sorrento Therapeutics, Inc.
7 Jul 23
Entry into a Material Definitive Agreement
9:49pm
8-K
EX-10.2
SRNEQ
Sorrento Therapeutics, Inc.
7 Jul 23
Entry into a Material Definitive Agreement
9:49pm
8-K
EX-10.1
nqqmpswu6qi
30 Mar 23
Sorrento Therapeutics, Inc. Receives Final Court Approval for $75 Million Debtor-In-Possession Financing
9:39pm
8-K
EX-10.1
d5yqh1jrnglc52csnmon
16 Dec 22
Departure of Directors or Certain Officers
4:10pm
425
EX-10.2
gywzfio3tt0ybdujh
13 Sep 22
Business combination disclosure
6:15pm
425
EX-10.1
i7sty1nc6 eow
13 Sep 22
Business combination disclosure
6:15pm
425
EX-10.3
3sv bjb2kbr
13 Sep 22
Business combination disclosure
6:15pm
8-K
EX-10.3
vyo 3zaje
13 Sep 22
Entry into a Material Definitive Agreement
6:14pm
8-K
EX-10.1
8e0id 4f6c5lae23p
13 Sep 22
Entry into a Material Definitive Agreement
6:14pm
8-K
EX-10.2
lnvtmg0n3yhpp
13 Sep 22
Entry into a Material Definitive Agreement
6:14pm
8-K
EX-10.1
e179jj5od
3 Jun 22
Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Repurchase of $41.4 Million of its Senior Secured Notes
9:00am
8-K
EX-10.2
imv4me te61f5f
28 Apr 22
Departure of Directors or Certain Officers
9:00am
8-K
EX-10.1
5wc rdquyxata
28 Apr 22
Departure of Directors or Certain Officers
9:00am
425
EX-10.1
h4niybjv5yp5qq3vzi4
18 Mar 22
Business combination disclosure
9:03am